Gene Solutions gets FDA priority as it eyes US launch

[ad_1]

Gene Solutions said the designation does not amount to FDA approval, as it targets a late-2026 US launch.
[ad_2]

[ad_1]

Gene Solutions said the designation does not amount to FDA approval, as it targets a late-2026 US launch.
[ad_2]


